Accuray Inc (ARAY)
1.93
+0.04
(+2.12%)
USD |
NASDAQ |
Nov 22, 16:00
1.93
0.00 (0.00%)
After-Hours: 20:00
Accuray Cash from Financing (Quarterly): -2.173M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -2.173M |
| June 30, 2024 | -0.694M |
| March 31, 2024 | -1.50M |
| December 31, 2023 | -0.257M |
| September 30, 2023 | -1.50M |
| June 30, 2023 | -0.522M |
| March 31, 2023 | -1.50M |
| December 31, 2022 | 4.275M |
| September 30, 2022 | -4.365M |
| June 30, 2022 | 0.141M |
| March 31, 2022 | -1.00M |
| December 31, 2021 | -13.51M |
| September 30, 2021 | -1.00M |
| June 30, 2021 | -19.41M |
| March 31, 2021 | 1.63M |
| December 31, 2020 | 0.136M |
| September 30, 2020 | -11.16M |
| June 30, 2020 | -1.63M |
| March 31, 2020 | 5.442M |
| December 31, 2019 | -4.566M |
| September 30, 2019 | 27.45M |
| June 30, 2019 | 13.76M |
| March 31, 2019 | 8.812M |
| December 31, 2018 | 8.327M |
| September 30, 2018 | -2.426M |
| Date | Value |
|---|---|
| June 30, 2018 | -2.813M |
| March 31, 2018 | -36.35M |
| December 31, 2017 | 12.88M |
| September 30, 2017 | -1.167M |
| June 30, 2017 | -13.11M |
| March 31, 2017 | -0.254M |
| December 31, 2016 | -5.69M |
| September 30, 2016 | -35.48M |
| June 30, 2016 | 0.237M |
| March 31, 2016 | -0.208M |
| December 31, 2015 | -0.76M |
| September 30, 2015 | -0.026M |
| June 30, 2015 | 1.183M |
| March 31, 2015 | 2.072M |
| December 31, 2014 | 0.754M |
| September 30, 2014 | 1.886M |
| June 30, 2014 | 1.183M |
| March 31, 2014 | 3.33M |
| December 31, 2013 | 3.235M |
| September 30, 2013 | 0.629M |
| June 30, 2013 | 1.90M |
| March 31, 2013 | 110.87M |
| December 31, 2012 | 4.896M |
| September 30, 2012 | 0.251M |
| June 30, 2012 | 1.745M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-19.41M
Minimum
Jun 2021
5.442M
Maximum
Mar 2020
-2.658M
Average
-1.25M
Median
Cash from Financing (Quarterly) Benchmarks
| Baxter International Inc | -146.00M |
| Boston Scientific Corp | 7.00M |
| Perspective Therapeutics Inc | 0.628M |
| Xtant Medical Holdings Inc | 5.314M |
| Catheter Precision Inc | 4.02M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.294M |
| Cash from Investing (Quarterly) | -1.12M |
| Free Cash Flow | -14.24M |
| Free Cash Flow Per Share (Quarterly) | -0.084 |
| Free Cash Flow to Equity (Quarterly) | -6.498M |
| Free Cash Flow to Firm (Quarterly) | -4.904M |
| Free Cash Flow Yield | -7.44% |